Skip to main content
Clinical Trials/NCT04811807
NCT04811807Not yet recruitingNot Applicable

Multicentre Observational Study of Impulsive Behaviours Following Deep Brain Stimulation in Parkinson's Disease

King's College London0 sites50 target enrollmentStarted: October 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
50
Primary Endpoint
Descriptive analysis of recurrence of ICBs in those with history of ICBs using scores on QUIP-RS/PICs

Study Overview

Brief Summary

The objective of this prospective observational cohort study is to answer the following clinically important questions:

  1. In patients with a pre-operative history of ICBs, what is the likelihood of improvement or deterioration in ICBs post-operatively?
  2. What is the risk of developing post-operative de novo ICBs after Subthalamic Nucleus DBS (STN DBS)?
  3. Which factors are important in predicting changes in ICBs after STN DBS?
  4. What is the impact of ICBs on carer's quality of life QoL and burden?

Detailed Description

The study will record outcomes related to ICBs for PD patients who have already been selected for DBS therapy as a routine clinical treatment in participating in DBS operating centre

It is routine practice to assess ICBs before DBS decisions are made, but the manner varies across DBS operating centres. The only additional factor to the routine DBS clinical pathway in this study is that the centres involved will perform assessments in a uniform manner to allow data to be combined. A unified set of clinical assessment scales for Impulsive Control Disorders ICDs and ICBs, as well as other relevant neuropsychiatric symptom assessment, will be added to routine pre- and post-operational clinical assessments for participants.

The primary endpoint of the study is the change in severity of ICBs. If subjects score above 1 in any of given questions on QUIP-RS, or if subjects had disagreement with carers regarding scores, The Parkinson's Impulse-Control Scale, PICs will be triggered. PICs then will be administered by our trained research fellow (AA), over phone or in the clinic.

Other scales to be administered are listed below:

  1. Neuropsychiatric Inventory (NPI)
  2. General anxiety disorder-7 (GAD-7)
  3. Patient Health Questionnaire-9 (PHQ9)
  4. Parkinson's disease questionnaire-39 (PDQ-39)
  5. EuroQol 5 Dimension (EQ-5D)
  6. Clinical Global Impression - Severity scale (CGI-S) at baseline and Clinician's Global Impression - Improvement scale (GGI-I) post-operatively.
  7. Zarit Caregiver Burden Scale
  8. Work and Social Adjustment Scale
  9. UPPS-P Impulsive Behaviour Scale

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Selected for DBS to treat motor symptoms of Parkinson's disease
  • English language fluency

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Descriptive analysis of recurrence of ICBs in those with history of ICBs using scores on QUIP-RS/PICs

Time Frame: 12 months

change in severity of ICBs and development of new ICBs

Time Frame: 12 months

Descriptive analysis of de novo cases of Impulsive control disorders ICD/ICBs

Time Frame: 12 months

Secondary Outcomes

  • predictive factors for de novo, recurrence and change in severity of ICD/ICBs(12 months)
  • change in ICB relate to quality of life in patients and carers(12 months)
  • change in ICD relates to change in personality traits(12 months)
  • change in ICD relates to changes in mood(12 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials